Hemoglobin Based Oxygen Therapeutics in Elective Percutaneous Coronary Revascularization

Clinical trial NCT00479895 · COMPLETED

Trial details

NCT number: NCT00479895
Sponsor: Biopure Corporation
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Coronary Occlusion Acute Coronary Syndrome

Start date: 2007-04-01
Primary completion: 2008-03-01
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.